Academician Huang Wenlin

　　Main achievements

　　Academician of the European Academy of Natural Sciences, professor of the Cancer Hospital of Sun Yat-sen University;

　　Selected as an expert in national key fields, enjoying special allowances from the State Council;

　　Served as an expert in the 973 Infectious Diseases Special Expert Group (12th Five-Year Plan);

　　Rotating Chairman of the Asia-Pacific Cell and Gene Therapy Association;

　　Deputy Director of the Gene Therapy Branch of the China Pharmaceutical Biotechnology Association;

　　Honorary Professor of the Chinese University of Hong Kong;

　　Resume

　　Professor Huang Wenlin presided over the national "11th Five-Year Plan to 13th Five-Year Plan" major new drug creation project, "863", "973" projects and many projects of the National Natural Science Foundation. He has obtained more than 30 invention patents in the United States, international PCT and China, and has won the 12th China Invention Patent Gold Award, the Second Prize of the National Science and Technology Progress Award, the First Prize of the Natural Science of the Ministry of Education, and the First Prize of the Guangdong Science and Technology Progress Award. Developed 5 innovative products for basic medical treatment and immunotherapy for tumors and metabolic diseases, developed China's first gene therapy drug and completed Phase III clinical trials (recombinant human endostatin adenovirus injection), and successfully transformed it into a product needed by the market.